Emerging Infectious Diseases

Papers
(The H4-Index of Emerging Infectious Diseases is 88. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients1262
High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 21136
Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital Wards, Wuhan, China, 2020762
COVID-19 Outbreak Associated with Air Conditioning in Restaurant, Guangzhou, China, 2020657
US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2479
Serial Interval of COVID-19 among Publicly Reported Confirmed Cases475
Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States467
Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings—Social Distancing Measures430
Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, Shenzhen, China, 2020427
Infectious SARS-CoV-2 in Feces of Patient with Severe COVID-19414
Indirect Virus Transmission in Cluster of COVID-19 Cases, Wenzhou, China, 2020392
Coronavirus Disease Outbreak in Call Center, South Korea385
Evidence Supporting Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 While Presymptomatic or Asymptomatic382
Contact Tracing during Coronavirus Disease Outbreak, South Korea, 2020378
Public Mental Health Crisis during COVID-19 Pandemic, China373
Detection of Novel Coronavirus by RT-PCR in Stool Specimen from Asymptomatic Child, China362
Potential Presymptomatic Transmission of SARS-CoV-2, Zhejiang Province, China, 2020362
Evaluating the Effectiveness of Social Distancing Interventions to Delay or Flatten the Epidemic Curve of Coronavirus Disease315
Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States303
Community Responses during Early Phase of COVID-19 Epidemic, Hong Kong295
Multicenter Epidemiologic Study of Coronavirus Disease–Associated Mucormycosis, India290
Risk for Transportation of Coronavirus Disease from Wuhan to Other Cities in China290
Human-to-Human Transmission of Monkeypox Virus, United Kingdom, October 2018286
Estimating the Frequency of Lyme Disease Diagnoses, United States, 2010–2018281
Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 by WHO-Recommended Hand Rub Formulations and Alcohols273
Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol Suspensions243
Rhabdomyolysis as Potential Late Complication Associated with COVID-19243
Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China243
Case-Fatality Risk Estimates for COVID-19 Calculated by Using a Lag Time for Fatality231
Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, China227
Decreased Influenza Incidence under COVID-19 Control Measures, Singapore224
SARS-CoV-2 Transmission between Mink (Neovison vison) and Humans, Denmark219
Possible Bat Origin of Severe Acute Respiratory Syndrome Coronavirus 2213
Identifying and Interrupting Superspreading Events—Implications for Control of Severe Acute Respiratory Syndrome Coronavirus 2210
Multidrug-Resistant Candida auris Infections in Critically Ill Coronavirus Disease Patients, India, April–July 2020208
Cluster of Coronavirus Disease Associated with Fitness Dance Classes, South Korea197
SARS-CoV-2 Virus Culture and Subgenomic RNA for Respiratory Specimens from Patients with Mild Coronavirus Disease190
Imported Monkeypox, Singapore188
Clusters of Coronavirus Disease in Communities, Japan, January–April 2020180
COVID-19–Associated Pulmonary Aspergillosis, March–August 2020167
Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil165
Effectiveness of N95 Respirator Decontamination and Reuse against SARS-CoV-2 Virus165
Prolonged Infectivity of SARS-CoV-2 in Fomites160
Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings—Personal Protective and Environmental Measures157
Estimate of Burden and Direct Healthcare Cost of Infectious Waterborne Disease in the United States157
Monitoring SARS-CoV-2 Circulation and Diversity through Community Wastewater Sequencing, the Netherlands and Belgium154
Transmission of SARS-CoV 2 During Long-Haul Flight154
Viral RNA Load in Mildly Symptomatic and Asymptomatic Children with COVID-19, Seoul, South Korea153
Case-Control Study of Use of Personal Protective Measures and Risk for SARS-CoV 2 Infection, Thailand149
Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France146
Severe Acute Respiratory Syndrome Coronavirus 2 RNA Detected in Blood Donations145
Estimating Risk for Death from Coronavirus Disease, China, January–February 2020145
Reemergence of Human Monkeypox and Declining Population Immunity in the Context of Urbanization, Nigeria, 2017–2020144
Asymptomatic and Human-to-Human Transmission of SARS-CoV-2 in a 2-Family Cluster, Xuzhou, China143
Imported Monkeypox from International Traveler, Maryland, USA, 2021142
Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan141
Prolonged Persistence of SARS-CoV-2 RNA in Body Fluids140
SARS-CoV-2 in Quarantined Domestic Cats from COVID-19 Households or Close Contacts, Hong Kong, China138
Probable Transmission of SARS-CoV-2 Omicron Variant in Quarantine Hotel, Hong Kong, China, November 2021138
SARS-CoV-2 Natural Transmission from Human to Cat, Belgium, March 2020137
Experimental Infection of Cattle with SARS-CoV-2136
Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020134
Susceptibility of Raccoon Dogs for Experimental SARS-CoV-2 Infection133
Effect of Environmental Conditions on SARS-CoV-2 Stability in Human Nasal Mucus and Sputum132
Aspergillosis Complicating Severe Coronavirus Disease128
Resurgence of Respiratory Syncytial Virus Infections during COVID-19 Pandemic, Tokyo, Japan126
Rapid, Sensitive, Full-Genome Sequencing of Severe Acute Respiratory Syndrome Coronavirus 2116
Policy Decisions and Use of Information Technology to Fight Coronavirus Disease, Taiwan114
Clinicopathologic and Immunohistochemical Findings from Autopsy of Patient with COVID-19, Japan114
Detection and Characterization of Bat Sarbecovirus Phylogenetically Related to SARS-CoV-2, Japan113
Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January–April 2020113
Isolation, Sequence, Infectivity, and Replication Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2111
Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient109
Culture-Competent SARS-CoV-2 in Nasopharynx of Symptomatic Neonates, Children, and Adolescents108
Viral Interference between Respiratory Viruses102
Collateral Benefit of COVID-19 Control Measures on Influenza Activity, Taiwan101
Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection99
Triplex Real-Time RT-PCR for Severe Acute Respiratory Syndrome Coronavirus 299
Comparison of Lyme Disease in the United States and Europe98
Suspected Cat-to-Human Transmission of SARS-CoV-2, Thailand, July–September 202198
Epidemiologic Evidence for Airborne Transmission of SARS-CoV-2 during Church Singing, Australia, 202097
Coronavirus Disease among Workers in Food Processing, Food Manufacturing, and Agriculture Workplaces95
Antibody Responses 8 Months after Asymptomatic or Mild SARS-CoV-2 Infection95
Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity93
Epidemiology of Coronavirus Disease in Gansu Province, China, 202091
Severe Fever with Thrombocytopenia Syndrome, Japan, 2013–201790
Coronavirus Disease among Persons with Sickle Cell Disease, United States, March 20–May 21, 202090
Geographic Expansion of Sporotrichosis, Brazil89
Population-Based Estimates of Chronic Conditions Affecting Risk for Complications from Coronavirus Disease, United States88
0.060002088546753